Mount Sinai Health Hackathon: A Model of Experiential Team Science Education and Entrepreneurship
Thursday, November 21, 2019
Pacific 10:00 am - 11:00 am
Mountain 11:00 am - 12:00 pm
Central 12:00 pm - 1:00 pm
Eastern 1:00 pm - 2:00 pm
*Registration will close 30 minutes prior to webinar start time.
Launched in 2016 and now in it’s fourth year, the Mount Sinai Health Hackathon offers an innovative and novel model for team science education and entrepreneurship. Borrowing this format from the technology world, the Health Hackathon brings together individuals to form interdisciplinary teams with the aim of creating an innovative technology to solve a current problem in medical science or healthcare. This forum taps into the notion of “citizen science” and integrates diverse capabilities and domain expertise of front-line clinical providers, with insight into clinical phenotypes and care delivery challenges, with individuals reflective of wide-range of disciplines including basic science, engineering, programming, product design and business.
From an organizers perspective, the Health Hackathon aims to bring participants together in transdisciplinary teams around a shared problem, fostering experiential learning through communication, collaboration and problem-solving. It aims to cultivate an environment for participants to develop the skills and knowledge for creating technology that addresses the needs and unique challenges of the healthcare environment, and to promote healthcare innovation and an entrepreneurial ecosystem at Mount Sinai and beyond.
In this webinar session, we aim to provide you with an overview of the Mount Sinai Health Hackathon experience by showcasing the vision, mission, outcomes and impact of this novel initiative. We will describe the planning involved to create a highly successful Health Hackathon, the content and format of the event, as well as outcome measures and evaluation tools we have utilized to measure the impact on team science. Our goal is to provide a new way to think about fostering team science, provide you with Health Hackathon best practices to consider, and inspire you to develop similar models of fostering team science education while promoting entrepreneurship.
Janice Gabrilove, MD, FASP and Layla Fattah, MPharm, MEd
Janice Gabrilove, MD, FASP
Janice Gabrilove, MD, FASP, is currently the James F. Holland Professor of Medicine, and serves as the Associate Director for Education and Training, the Tisch Cancer Institute (an NCI Designated Cancer Center), Director of the Clinical Research Education Program (Certificate, Master of Science in Clinical Research [MSCR], and PhD in Clinical Research Program), Director of our NCATS funded NRSA pre and post-doctoral (exclusively URM focused) TL1 Training Program and oversees Workforce Development for ConduITS, the Icahn School of Medicine Institute for Translational Sciences, CTSA. Dr. Gabrilove is a pioneer in the development of our understanding of the biology of hematopoietic growth factors and their clinical utility in promoting hematopoietic reconstitution in the setting of iatrogenic and disease related neutropenia. She is a named inventor and patent holder for Arsenic Trioxide (Trisenox), a curative therapeutic for Acute Promyelocytic Leukemia and for the discovery and clinical application of Human G-CSF (marketed as Neupogen and Neulasta ) and previously served on the FDA Advisory Committee for the approval of Biologic Therapeutics. Her clinical and translational studies demonstrated the ability of G-CSF to accelerate recovery from chemotherapy-induced and disease related neutropenia as well as mobilize progenitor cells into the peripheral blood. This latter observation ushered in the era of Peripheral Blood Progenitor Cell Transplantation (PBPC). In her role as a clinical investigator she has mentored more than 30 successful clinical investigators and trialists.
A member of the American Society for Clinical Investigation (ASCI), Dr. Gabrilove has previously served as Vice Chair and Chair of the Education Key Function Committee of the NIH Clinical Translational Science Award (CTSA) consortium, during which time she led a working group on Mentored to Independence, resulting in the publication of several white papers in Academic Medicine on this topic. She has also served as the Scientific Program Chair of Translational Science 2016 and Chair of the ACTS Education Committee from May 2017-March of 2019. She currently resides as a member of the ACTS Education Committee.
Layla Fattah, MPharm, MEd
Layla Fattah is currently the Education Program Manager for Workforce Development for ConduITS. She is a UK-qualified Clinical Pharmacist, having practiced for 12 years in the UK National Health Service within the largest teaching hospital in Europe. She led the experiential component of the Master of Pharmacy program at the University of Manchester and established a clinically integrated experiential program of practice and work-based assessment. Alongside this role, she was Program Director for an innovative and highly successful program in Independent Prescribing for pharmacists and nurses. She has a background in curriculum development, instructional design and program evaluation, having developed and launched a wide range of online, blended and workshop-based educational initiatives and programs.
Layla has a Masters in Education from the University of Leeds and a Masters in Pharmacy from the University of Manchester. She has a particular interest in education within the context of organizational change, and is currently working toward a Doctorate in this field.
Handouts for the presentation can be downloaded closer to the presentation date.
We will be using Zoom for this live webinar. To ensure that your system meets all requirements needed to use Zoom, visit the Zoom site and scan your system. Click here to run a system check on your computer.
If you have any questions, please call ACTS at 800.367.1119 or e-mail firstname.lastname@example.org.